SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-057139
Filing Date
2024-05-09
Accepted
2024-05-09 16:35:48
Documents
53
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q xene-20240331.htm   iXBRL 10-Q 1615477
2 EX-10.1 xene-ex10_1.htm EX-10.1 74563
3 EX-31.1 xene-ex31_1.htm EX-31.1 14829
4 EX-31.2 xene-ex31_2.htm EX-31.2 14803
5 EX-32.1 xene-ex32_1.htm EX-32.1 10702
6 EX-32.2 xene-ex32_2.htm EX-32.2 10157
  Complete submission text file 0000950170-24-057139.txt   5684830

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT xene-20240331.xsd EX-101.SCH 764873
57 EXTRACTED XBRL INSTANCE DOCUMENT xene-20240331_htm.xml XML 825386
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36687 | Film No.: 24931367
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)